Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: rFSH vs rFSH+rLH in Dydrogesterone-Based Progestin Protocol: A Prospective Study

View source ↗

Summary

A prospective study comparing recombinant FSH alone versus recombinant FSH with recombinant LH within a dydrogesterone-based progestin IVF protocol; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • recombinant FSH (follicle-stimulating hormone)
  • recombinant LH (recombinant luteinizing hormone)

Snippet

Sponsor: Centrum Clinic IVF Center | Conditions: InVitro Fertilization, Gonadotropins | Status: RECRUITING